what are the glp 1 drug names Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer GLP-1 Costs Explained: Managing Coverage
Description
Preclinical studies suggested that GLP-1RAs reduced immune cell activity and oxidative stress in kidney and led to decrease in fibrosis [15, 45]
Future research should aim to address the therapeutic efficacy of GLP-1RAs in human trials and elucidate the mechanisms behind it
January 2025
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
Biotechnology Companies Risk
